Sustained anti-pruritic effect in mice with TP- 2021, a kappa opioid agonist peptide, delivered by subdermal ProNeura® Implants B. B. Land1, S. Sreedharan2, R. Patel2, T. Beck3, K. DeVarney2, M. Rubin2, *C. Chavkin1
Tuesday, November 9, 2021 1 min read
Key Takeaway: Charles Chavkin, Ph.D. Sophia Mar Sunil Sreedharan, Ph.D. Raj Patel, Ph.D. Tyler Beck Kate DeVarney, Ph.D. Marc Rubin, M.D. Funding University of Washington Reagents Titan Pharmaceuticals
Full Press Release Details
Charles Chavkin, Ph.D. Sophia Mar Sunil Sreedharan, Ph.D. Raj Patel, Ph.D. Tyler Beck Kate DeVarney, Ph.D. Marc Rubin, M.D. Funding University of Washington Reagents Titan Pharmaceuticals